
Thursday, September 03, 2020 1:44:02 AM
This Court does not have sufficient information from her written opinion to be certain, beyond any doubt, of the sequence of Judge Du’s mental reasoning as distinct from her written opinion. Nor can we be sure that, if indeed she did use incorrect sequencing, she would not have reached the same conclusion based on the evidence before her had she followed the correct sequencing.
Further, this Court, having not had the benefit of the direct evidence, is unwilling to overturn the decision because Judge Du’s findings of facts, while potentially incorrect, are not in our view clearly and obviously incorrect, and the briefs/oral arguments highlight significant differences between the parties as to the underlying facts.
We therefore find that the case should be remanded to Judge Du for her to reconsider her decision, and the evidence, based on
(1) clearly separating out the obviousness argument from ones relating to secondary considerations,
(2) clearly first coming to an interim conclusion on obviousness without any initial contemplation whatsoever of secondary considerations,
(3) bearing in mind the very high burden of proof on the defendants when it comes to obviousness; and
(4) bearing in mind that even if she does reach the same interim conclusion on obviousness, she should then evaluate secondary considerations as a check against that interim conclusion, but without weighing them against each other.

Liked By
Spread the love. Be the first to like this post!
Recent AMRN News
- Reconstituted Amarin Board Ready for the Challenge of Unlocking True Potential of VASCEPA®/VAZKEPA® (Icosapent Ethyl) • GlobeNewswire Inc. • 03/16/2023 12:00:00 PM
- Nightfood, Inc. (OTCQB: NGTF) now in Sonesta International Hotels Multiple Brands • InvestorsHub NewsWire • 03/13/2023 11:35:55 AM
- Initial Statement of Beneficial Ownership (3) • Edgar (US Regulatory) • 03/10/2023 11:34:16 PM
- Initial Statement of Beneficial Ownership (3) • Edgar (US Regulatory) • 03/10/2023 11:34:01 PM
- Initial Statement of Beneficial Ownership (3) • Edgar (US Regulatory) • 03/10/2023 11:33:42 PM
- Initial Statement of Beneficial Ownership (3) • Edgar (US Regulatory) • 03/10/2023 11:33:30 PM
- Initial Statement of Beneficial Ownership (3) • Edgar (US Regulatory) • 03/10/2023 11:32:42 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 03/08/2023 01:31:04 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 03/08/2023 01:30:53 PM
- Amarin Announces Board Departures • GlobeNewswire Inc. • 03/06/2023 09:05:43 PM
- Amarin Highlights New Evidence of Therapeutic Value of EPA in Reducing Cardiovascular Events in At-Risk Patients Presented at ACC.23/WCC • GlobeNewswire Inc. • 03/06/2023 01:00:00 PM
- Amarin Announces New REDUCE-IT® Data at ACC.23/WCC Showing Benefit of VASCEPA®/VAZKEPA® (Icosapent Ethyl) in High-Risk Patients with a Recent Acute Coronary Syndrome Event • GlobeNewswire Inc. • 03/05/2023 03:21:00 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 03/02/2023 01:46:36 PM
- Annual Report (10-k) • Edgar (US Regulatory) • 03/01/2023 12:38:15 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 03/01/2023 12:07:12 PM
- Amarin Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update • GlobeNewswire Inc. • 03/01/2023 12:00:00 PM
- Additional Proxy Soliciting Materials - Non-management (definitive) (dfan14a) • Edgar (US Regulatory) • 02/28/2023 04:29:47 PM
- Amended Statement of Beneficial Ownership (sc 13d/a) • Edgar (US Regulatory) • 02/28/2023 04:20:41 PM
- Sarissa Capital Wins Proxy Contest Against Amarin by Huge Landslide • Business Wire • 02/28/2023 03:39:00 PM
- Amarin Announces Preliminary Voting Results Following 2023 General Meeting of Shareholders • GlobeNewswire Inc. • 02/28/2023 03:38:06 PM
- Amarin and CSL Seqirus Announce Exclusive License and Distribution Agreement to Commercialize VAZKEPA® (Icosapent Ethyl) in Australia and New Zealand • GlobeNewswire Inc. • 02/28/2023 01:00:55 PM
- Amarin Sets the Record Straight on Sarissa’s Latest Misstatements • GlobeNewswire Inc. • 02/27/2023 09:29:23 PM
- Amended Statement of Beneficial Ownership (sc 13d/a) • Edgar (US Regulatory) • 02/27/2023 09:06:19 PM
- Additional Proxy Soliciting Materials - Non-management (definitive) (dfan14a) • Edgar (US Regulatory) • 02/27/2023 09:06:16 PM
- Amarin Corporation to Present New Data Evaluating VASCEPA®/VAZKEPA® (Icosapent Ethyl) at ACC.23/WCC • GlobeNewswire Inc. • 02/27/2023 01:00:00 PM
FEATURED Fineqia's EEA Unit Receives Approval of Base Prospectus for Issuing Exchange Traded Notes (ETNs) • Mar 28, 2023 9:37 AM
FEATURED Usha Resources Enters Hard-Rock Lithium Space with Acquisition of Significant Ontario Land Package with Highly Evolved LCT-Pegmatites • Mar 28, 2023 8:26 AM
FEATURED Edison Lithium Provides Update on Spin-Out of Cobalt Assets • Mar 28, 2023 8:09 AM
FEATURED Epazz Holdings: ZenaDrone, Inc. 1000 AI Predictive Received a Letter of Support from the US Airforce for Drone Cargo Delivery and Intent to Use ZenaDrone 1000 Platform • Mar 28, 2023 7:11 AM
Metatron Releases All-in-One Artificial Intelligence Mobile Apps for iPhone and Android • MRNJ • Mar 27, 2023 9:00 AM
Memorandum of Understanding With Miranda Water Treatment Systems and Rainmaker Worldwide Inc. Extended • RAKR • Mar 27, 2023 8:50 AM